Stahl's essential psychopharmacology : neuroscientific basis and practical applications / Stephen M. Stahl ; editorial assistant, Meghan M. Grady ; with illusttations by Nancy Muntner.
- 作者： Stahl, Stephen M., 1951- author.
- 其他作者：
- 其他題名：
- Essential psychopharmacology.
- Cambridge medicine (Series)
- 出版： New York : Cambridge University Press 2021.
- 叢書名： Cambridge medicine
- 主題： Mental illness--Chemotherapy. , Psychopharmacology. , Mental Disorders--drug therapy. , Central Nervous System--drug effects. , Psychotropic Drugs--pharmacology. , Mental illness--Chemotherapy. , Psychopharmacology.
- 版本：Fifth edition.
- ISBN： 9781108971638 (pbk.): NT$2700 、 9781108838573 (bound) 、 110883857X (bound) 、 1108971636 (pbk.)
- 一般註：Includes bibliographical references and index.
-
讀者標籤：
- 系統號： 000288916 | 機讀編目格式
館藏資訊
Long established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
摘要註
"For this 5th edition of Stahl's Essential Psychopharmacology you will notice that every figure in the book has been revised, refreshed and updated with new colors, shading and outlining. About half the figures are entirely new. The number of chapters has decreased by one, with merger of mood stabilizers into treatments for mood disorders; the text itself and the total number of figures and tables are all approximately the same in length and number, although all chapters have been edited, most of them extensively with the details of what has changed listed below. The number of references has now been doubled. Overall, 14 drugs have new uses and indications presented, and 18 brand new drugs are introduced and discussed"--
